Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
The Job of a Migration Legal advisor: How They Can Help You - 2Cyber Monday Paramount+ deal: Save 50% and stream these buzzy Taylor Sheridan shows
- 3Step in Style: A Survey of \Solace and Execution on the Track\ Running Shoes
- 4The Oscars are moving from ABC to YouTube starting in 2029
- 5Doggie diversity in size and shape began at least 11,000 years ago
- A Manual for the Right SUV for Seniors
- Go With The Breeze: Grand Paragliding Spots On the planet
- Pick Your Favored kind of sandwich
- Nutrient Rich Organic products: Lift Your Wellbeing
- San Francisco sues 10 companies that make ultraprocessed food
- Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- South America's Memorable Destinations: A Movement Guide
- 10 Picturesque Campgrounds That Will Raise Your Outside Involvement with American
- Excursion to Different Universes: the Top Sci-fi Motion pictures Ever
